Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00055848 · ClinicalTrials.gov registry record
Genetic Study of Familial Factors in Patients With Colon Cancer
A clinical trial, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- 600
- Enrollment target
NCT00055848: Completed study, sponsored by Alliance for Clinical Trials in Oncology.
NCT00055848 is a clinical trial that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 600 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00055848 has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- 600 participants
- Enrollment target
Study Summary
RATIONALE: Genetic studies may help in understanding the genetic processes involved in the development of some types of cancer. PURPOSE: Clinical trial to study the cancer-related genes in patients who have colon cancer or adenomatous polyps.
Interventions
- GENETIC microarray analysis
- GENETIC cytogenetic analysis
- GENETIC gene mapping
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2001-12 |
| Est. Completion | 2010-10 |
What the finished NCT00055848 record still lists
NCT00055848 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which microarray analysis is the first listed.
NCT00055848 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00055848 about?
NCT00055848 is a clinical study titled "Genetic Study of Familial Factors in Patients With Colon Cancer". RATIONALE: Genetic studies may help in understanding the genetic processes involved in the development of some types of cancer. PURPOSE: Clinical trial to study the cancer-related genes in patients who have colon cancer or adenomatous polyps.
What is the current status of trial NCT00055848?
This trial is currently completed. The enrollment target is 600 participants. The study started on 2001-12. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00055848?
The interventions under investigation include: microarray analysis (GENETIC), cytogenetic analysis (GENETIC), gene mapping (GENETIC).
Who is sponsoring clinical trial NCT00055848?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia